应力颗粒
颗粒(地质)
神经退行性变
细胞生物学
化学
核糖核酸
小分子
生物
生物化学
信使核糖核酸
疾病
基因
医学
翻译(生物学)
古生物学
病理
作者
Brian D. Freibaum,James Messing,Haruko Nakamura,Ugur Yurtsever,Jinjun Wu,Hong Joo Kim,Jeff Hixon,Rene Marc Lemieux,Jay L. Duffner,Walter Huynh,Kathy Tin Kam Wong,Michael R. White,Christina Lee,Rachel E. Meyers,Roy Parker,J. Paul Taylor
标识
DOI:10.1083/jcb.202308083
摘要
Stress granule formation is triggered by the release of mRNAs from polysomes and is promoted by the action of the RNA-binding proteins G3BP1/2. Stress granules have been implicated in several disease states, including cancer and neurodegeneration. Consequently, compounds that limit stress granule formation or promote their dissolution have potential as both experimental tools and novel therapeutics. Herein, we describe two small molecules, G3BP inhibitor a and b (G3Ia and G3Ib), designed to bind to a specific pocket in G3BP1/2 that is targeted by viral inhibitors of G3BP1/2 function. In addition to disrupting the co-condensation of RNA, G3BP1, and caprin 1 in vitro, these compounds inhibit stress granule formation in cells treated prior to or concurrent with stress and dissolve pre-existing stress granules. These effects are consistent across multiple cell types and a variety of initiating stressors. Thus, these compounds represent powerful tools to probe the biology of stress granules and hold promise for therapeutic interventions designed to modulate stress granule formation.
科研通智能强力驱动
Strongly Powered by AbleSci AI